Stretching the mutant prevention concentration (MPC) beyond its limits.
about
Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.The changing face of antibiotic prescribing: the mutant selection window.Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistanceIn vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.Recent developments in the clinical activity of topoisomerase-1 inhibitors.Optimizing drug exposure to minimize selection of antibiotic resistance.Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.Antimicrobial-resistant Streptococcus pneumoniae: trends and management.Bacteraemic pneumococcal pneumonia: current therapeutic options.Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes.Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.Mutant prevention concentrations of four carbapenems against gram-negative rods.Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens.Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos).Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
P2860
Q28552950-17C686CC-012E-42DB-876B-90F580E849F3Q34057612-A72F1DE8-2DE4-4D43-953A-F648F472EF16Q35875929-F856D9BF-2F24-487D-8CA5-0F6595B52745Q36086509-DBD5691E-DFA7-4F84-AD86-49F0F82B4E46Q36187937-DC4D72EC-DE85-4B25-993A-3CA1EBE24D69Q36234871-3F7711E2-A878-494B-8DC1-7CED6644A5B0Q36903693-82BBE7A8-67D5-4A26-93C0-CC0DB2D39479Q37188061-34A3C36B-1CE6-4B31-A476-4FEBA3B6A25BQ37291341-6CB3D14B-E6CA-4859-9D54-E85AD1720853Q37833059-60566C56-3D54-4ADC-8C40-1AF4F198B2F6Q37861190-0F265711-9C46-4457-95A3-B7F39440A6DBQ38808661-AB8566C2-18EB-4FD8-9A87-CA469AFE876EQ38977280-880EFE66-8DB8-42DA-B555-AA221AE13471Q39108922-DAB90341-DF05-44BC-967B-A1ABD88DD8CEQ40749260-3748B564-696A-4F67-AF66-AF4B021B4E8BQ42249678-84F931A9-1B9B-4BD9-8582-E49A1EFC4056Q42612081-890A014D-1043-47E5-B638-5FEEC2E576DCQ42708766-BB203AFA-8F8E-462C-BE9E-66B278061E47Q43243027-0832745A-127B-40B0-BBF6-84AC84118A1FQ43407783-27DFD7A8-F1BA-4882-B904-3D4E06866C4CQ59101206-E3EA8700-254D-40EF-9A7F-DFCCAF18D1E8
P2860
Stretching the mutant prevention concentration (MPC) beyond its limits.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Stretching the mutant prevention concentration (MPC) beyond its limits.
@ast
Stretching the mutant prevention concentration (MPC) beyond its limits.
@en
type
label
Stretching the mutant prevention concentration (MPC) beyond its limits.
@ast
Stretching the mutant prevention concentration (MPC) beyond its limits.
@en
prefLabel
Stretching the mutant prevention concentration (MPC) beyond its limits.
@ast
Stretching the mutant prevention concentration (MPC) beyond its limits.
@en
P2093
P356
P1476
Stretching the mutant prevention concentration (MPC) beyond its limits.
@en
P2093
Daryl J Hoban
Heather J Smith
Kimberly A Nichol
P304
P356
10.1093/JAC/DKG255
P407
P577
2003-04-25T00:00:00Z